Clinical trial
Evaluation of Atuna Racemosa Toxicity
NCT00318344 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00318344 |
|---|---|
| Title | Evaluation of Atuna Racemosa Toxicity |
| Official title | Evaluation of Atuna Racemosa Toxicity |
| Lead sponsor | Mayo Clinic, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Bacterial Infections |
| Intervention type | Drug |
| Interventions | Atuna Racemosa |
| Enrollment | 20 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Apr 26, 2006 |
| Last update posted | Feb 2, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: